BioCentury
ARTICLE | Clinical News

Ambulight PDT regulatory update

August 1, 2011 7:00 AM UTC

The U.K.'s NICE issued final guidance concluding that the case for adopting Ambicare's Ambulight photodynamic therapy (PDT) to treat non-melanoma skin cancer over current management could not be suppo...